You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Casi Pharms Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for CASI PHARMS INC, and what generic and branded alternatives to CASI PHARMS INC drugs are available?

CASI PHARMS INC has seven approved drugs.



Summary for Casi Pharms Inc
US Patents:0
Tradenames:6
Ingredients:6
NDAs:7

Drugs and US Patents for Casi Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casi Pharms Inc ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077517-002 Jun 25, 2007 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Casi Pharms Inc CILOSTAZOL cilostazol TABLET;ORAL 077310-001 Nov 8, 2005 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Casi Pharms Inc ENTECAVIR entecavir TABLET;ORAL 206672-001 May 11, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Casi Pharms Inc TIZANIDINE HYDROCHLORIDE tizanidine hydrochloride TABLET;ORAL 076280-002 Jun 27, 2002 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.